Page 1,521«..1020..1,5201,5211,5221,523..1,5301,540..»

Cyclist turns a death sentence into a race against diabetes – CNN

Posted: April 29, 2017 at 3:40 am

"My mom took me to one doctor who said, 'Your kid has got the flu. Come back in one week,'" he said.

"They said, 'Ma'am, we've got good news, and we've got bad news. The good news is your son's gonna live for now. The bad news is, he's got diabetes. He's got to take shots of insulin, and most likely he'll be dead by 25. If not, he'll either be blind or have renal failure,'" he said.

As he grew up in Tallahassee, Florida, Southerland was determined not to let this death sentence stop him. At 6, he was already managing his Type 1 diabetes on his own.

"For me, it was all I ever knew. I knew I had to breathe, I knew I had to eat and I knew I had to check my blood sugar and give myself insulin shots."

His parents stored only healthy food in the house to keep him from making bad choices. But at 12, Southerland disobeyed the rules and ate a candy bar. That decision would change his life.

"I figured OK, I don't want to wait two hours for my insulin to kick in. I do want to eat these candy bars. How can I do it?" he recalled.

So he hopped on his bike and rode through the neighborhood until his legs got tired.

"That was my journey to start riding," he said. "The bike for me was freedom."

The more he exercised, the less insulin he needed, and the easier it was to manage the disease.

"The bike gave me the discipline and motivation I needed to control my diabetes," he added.

The first sporting goal of the organization was to have a team of athletes compete in the Race Across America, a 3,000-mile bike trek through 12 states.

"We lost the race by three minutes," Southerland said. "So we came back the next year a little smarter in how we manage diabetes, a little more experienced in the race, and we set a world record of 5 days, 15 hours and 43 minutes."

To ensure safety, the organization provides a medical team to support riders during a race. Cyclists undergo a stringent testing regime in the three hours leading up to a race. They also use continuous glucose monitoring, which will sound an alarm if their levels get too high or too low.

In 2008, Southerland created a professional team of diabetic cyclists.

"I was supposed to be dead when we started Team Type 1 as a professional cycling team," he said.

But he was far from it. Southerland competed as a professional cyclist for two years until some injuries took him out of the sport.

Now 35, Southerland's goal is to field the first all-diabetic team in the Tour de France by 2021.

"I believe sport can be the unifying point for people with diabetes," he said.

Southerland's other passion is helping diabetic kids in Rwanda get much-needed medical supplies.

"I nearly put our company out of business in 2010 ... because I bought 400 blood glucose monitors, and I took about 40,000 test strips in bike boxes to the Tour of Rwanda," he said.

"We gave them out to the kids there. Their parents were all in tears because their kids have this tool, which is gonna help them live," he added. "It ripped my heart out."

Every year since then, the organization has continued to send supplies to Rwanda.

"I want every kid with diabetes to know that they are the hero. Every person with diabetes to know that their dreams can come true."

Read the rest here:
Cyclist turns a death sentence into a race against diabetes - CNN

Posted in Diabetes | Comments Off on Cyclist turns a death sentence into a race against diabetes – CNN

Smartphone ‘orders’ body to treat diabetes – BBC News

Posted: April 29, 2017 at 3:40 am


BBC News
Smartphone 'orders' body to treat diabetes
BBC News
Scientists have used a smartphone to control the activity of the living cells inside an animal. The fusion of biology and technology was used to control blood sugar levels in mice with diabetes. The idea, described in Science Translational Medicine ...
We Now Have an App That Can Activate Cells That Manage DiabetesFuturism
Smartphone App Enables Wireless Control of Diabetes | GENGenetic Engineering & Biotechnology News
Forget shots diabetes smartphone app tells cells when to produce ...New Atlas
Seeker -Science Daily -IEEE Spectrum
all 17 news articles »

See the rest here:
Smartphone 'orders' body to treat diabetes - BBC News

Posted in Diabetes | Comments Off on Smartphone ‘orders’ body to treat diabetes – BBC News

Type 2 Diabetes May Be Bad for Brain Health – WebMD

Posted: April 29, 2017 at 3:40 am

By Serena Gordon

HealthDay Reporter

THURSDAY, April 27, 2017 (HealthDay News) -- Previous research has linked type 2 diabetes and memory loss. Now, new research may be closing in on some of the reasons why.

The study found that people with type 2 diabetes -- particularly those who are overweight or obese -- have thinner gray matter in several areas of the brain.

These brain regions are related to memory, executive function, movement generation and visual information processing, said the study's senior author, Dr. In Kyoon Lyoo. He's director of the Ewha University Brain Institute in Seoul, South Korea.

"Obesity leads to increased risk of type 2 diabetes, metabolic dysfunction and is also associated with brain alterations independently," Lyoo said. "We aimed to investigate whether overweight/obesity influenced brain structure and cognitive function in individuals with early stage of type 2 diabetes."

The study included: 50 overweight or obese people with type 2 diabetes; 50 normal-weight people with type 2 diabetes, and 50 normal-weight people without diabetes.

The Korean study volunteers were between 30 and 60 years old. Those with diabetes had it for five years or less, and they were attempting lifestyle modifications and/or taking oral medication to lower blood sugar levels. No one was taking insulin.

The normal-weight group with type 2 diabetes had slightly better blood sugar control -- a hemoglobin A1C level of 7 percent. The overweight folks with type 2 diabetes had hemoglobin A1C levels of 7.3 percent.

Hemoglobin A1C is a two- to three- month estimate of average blood sugar levels. The American Diabetes Association generally recommends an A1C of 7 percent or less.

All study participants underwent MRI brain scans and tests to measure memory and thinking skills.

"Cortical thickness was decreased in several regions of the diabetic brains. Further thinning of the temporal lobes found in overweight/obese individuals with type 2 diabetes suggests that these regions are specifically vulnerable to combined effects of obesity and type 2 diabetes," Lyoo said.

He said this study alone cannot tease out whether the effect is from excess weight or diabetes or both. But the study did find that the longer someone had diabetes, the more likely they were to have brain changes.

Lyoo said factors such as insulin resistance, inflammation and poor blood sugar management might bring about the changes.

Memory and thinking skills were decreased in people with diabetes -- regardless of weight -- compared to the normal-weight people without type 2 diabetes, the study found.

Because the study only included an Asian population, Lyoo said it isn't clear if these effects would apply to other populations, such as Americans. He also said it isn't known if these effects occur in people with type 1 diabetes, the less common form of diabetes.

Dr. Sami Saba is an attending physician in neuromuscular medicine and electromyography at Lenox Hill Hospital in New York City.

"The regions most affected were the temporal lobes, which are also most prominently affected in people with Alzheimer's," he said of the research.

"While this was not proven on this study, it does suggest that those with diabetes who are also overweight are at higher risk for developing Alzheimer's-type cognitive impairment than those with diabetes who are not overweight," Saba said.

But, he also noted that a major limitation of this study was the lack of overweight/obese people without diabetes to serve as a comparison group.

The take-home message, said Saba, is that weight control is an "important factor in preserving brain health in these patients." He said it's one more reason to work to prevent weight gain.

Lyoo said good blood-sugar management would probably help slow down or prevent these diabetes- or obesity-related brain changes.

Dr. William Cefalu is the chief scientific, medical and mission officer for the American Diabetes Association.

"The presence of overweight and obesity has been shown in other studies to be associated with early structural changes in the brain, and may contribute to cognitive issues," he said.

But, he said that diabetes may also play a role. Both Lyoo and Cefalu said that more research is needed to figure out which factor is at the root of these changes.

The study was released April 27 in the journal Diabetologia.

WebMD News from HealthDay

SOURCES: In Kyoon Lyoo, M.D., Ph.D., director, Ewha University Brain Institute, Seoul, South Korea; Sami Saba, M.D., attending physician in neuromuscular medicine and electromyography, department of neurology, Lenox Hill Hospital, New York City; William Cefalu, M.D., chief scientific, medical and mission officer, American Diabetes Association; April 27, 2017, Diabetologia

Link:
Type 2 Diabetes May Be Bad for Brain Health - WebMD

Posted in Diabetes | Comments Off on Type 2 Diabetes May Be Bad for Brain Health – WebMD

Milton father runs North Pole half-marathon for diabetic son – Atlanta Journal Constitution

Posted: April 29, 2017 at 3:40 am

Many parents say that they will do anything for their children, but for Doug Wright, that meant going to the top of the world and enduring freezing temperatures.

The 58-year-old stay-at-home dad from Milton wanted to do something to raise awareness for Type 1 diabetes, a disease his 8-year-old son Jake lives with.

Earlier this month, Wright ran a half-marathon in the North Pole. He didnt see Santas Workshop or any polar bears, but Wright raised more than $4,500 for the Juvenile Diabetes Research Foundation.

Going to the North Pole for me was drawing that extreme, Wright said. People ask, Why are you doing that? and I say, Well, because my kid has Type 1 diabetes and I think thats pretty freakin extreme. So, Im going to do what I can to support him.

With nine children coming before Jake, Wright and his wife thought they had seen everything. They knew how to handle all types of illnesses and injuries any kid might get.

Jake started getting sick in Febuary 2016. He was vomiting often, he didnt want to eat and he wasnt getting better.

Wright took his boy to the nearest hospital and after a nurse and doctor saw him they told Wright that his youngest son was in distress and that they couldnt help him. Wright scooped Jake off the table and took him to Children's Healthcare of Atlanta at Scottish Rite Hospital where he got the proper care he needed.

To have that facility here is a blessing to those who live in this area, Wright said. I think if I had to drive another 20 minutes, we wouldve lost Jake. By the time we got there, he was incoherent.

While medical professionals were working on Jake, a doctor stepped away from the table to ask Wright if there was a history of diabetes in the family. Wright said, No. Not at all. Nothing.

Jake had tubes in his arms, his clothes were ripped off, and doctors were trying everything. Finally, a doctor turned to Wright and told him they were going to treat Jake as if he had Type 1 diabetes. And it worked. Jake was stabilized and began getting better.

The doctor started talking about a lot of things, but all I heard him say was that my son was going to live, Wright said. Thats all I wanted to know.

Jake nearly died from diabetic ketoacidosis and was eventually diagnosed with Type 1 diabetes. Then, the in-home care started.

With todays technology, Jake and his family can constantly monitor his blood glucose levels on his iPhone with the use of a device called a Dexcom, an FDA approved device that can be attached to a diabetics body and will send readings using Bluetooth.

Shortly after discovering Jake had diabetes, Wright and his wife began researching the disease and looking at organizations who were raising money for research and awareness. The one they liked the most was JDRF, the Juvenile Diabetes Research Foundation.

Theres no hidden dream or agenda with them, Wright said. They do what they can to help (diabetics) live a normal life. Theres an understanding that, they may never find a cure, but theyre going to make sure (diabetics) wake up in the morning and (live) like the rest of us do.

Doug Wright "dabs" for his son in the North Pole. Submitted

Wright eventually got the feeling that he wanted to do something extreme to show his son he had his back with his extreme disease.

Scrolling through Facebook one day, he saw an ad and article on the North Pole Marathon. Wright said he hadnt ran a race since 1996, but that didnt stop him his mind was made up and he began training.

Wright prepped his body and arrived in the North Pole on April 9 to run a half-marathon. He wore many layers for the race that included more than 50 people from 24 countries. The temperatures dipped down to 40 degrees below zero.

Ten miles into the race, cramps kicked in and Wright found himself on his back in the snow. He was punching the ground in a fit of rage. Eventually, two other runners came along and helped him stretch. Wright was good to go and completed six more miles.

The track of the marathon includes a tent where runners can go in, hydrate, change clothes and warm up. Wright says he changed clothes three times because wearing sweaty clothes can result in hypothermia and he was out on the ice for eight hours. He thinks he did well for someone who hadnt ran a race in 21 years.

And Wright did raise some money for JDRF too. As of April 28, he had raised $4,528.44. Folks who wish to donate to the cause can visit thedonation page.

You dont go to the North Pole to set land-speed records, Wright said. You go there for the experience and a cause. When I heard about the North Pole marathon, I talked to my wife and said, You know, we talk about going to the ends of the Earth for our children. How about we do it?.

Like North Fulton County News Now onFacebook | Follow onTwitterandInstagram

Scientists In Texas Closer To Diabetes Cure With Unconventional Treatment

Follow this link:
Milton father runs North Pole half-marathon for diabetic son - Atlanta Journal Constitution

Posted in Diabetes | Comments Off on Milton father runs North Pole half-marathon for diabetic son – Atlanta Journal Constitution

Meet Curry Cates: 2017 Big Man on Campus – The Auburn Plainsman

Posted: April 28, 2017 at 1:52 am

By Claire Tully | Campus Editor | 14 hours ago Image by Kae Henderson | Photographer | The Auburn Plainsman

Curry Cates, contestant and winner of the 22nd annual Big Man on Campus Pageant on Thursday, April. 13, 2017, in Auburn, Ala.

Zeta Tau Alpha's Gamma Rho chapter on campus hosts the Big Man on Campus event each spring to raise money for breast cancer research in the form of an all-male pageant.

Contestants performed in opening numbers, individual talents, dressed in formal wear and answered on stage questions at the event, in addition to collaborating with the sororities to raise funds prior to the pageant.

This year,Curry Cates, junior in health services administration , was crowned the winner after impressing judges with his performance of "You Raise Me Up" by Josh Groban.

"My entire family can sing," Cates said."My dad, sister, grandparents, so I grew up in church singing and sang in choir in high school."

Cates said singing has been a hobby of his for years, so it made sense he chose to perform a song during the pageant's talent segment.

"During high school I attended Alabama Allstate chorus all 4 years, and I started taking voice lessons," Cates said."I participated in NATS (National Association of Teachers of Singing) competition where I placed 1st in my category senior year. I have always enjoyed singing, and love being able to sing with family and friends."

As for the fundraising portion of the competition, Cates said he worked closely with Tri Delta.

"I partnered with my nominating sorority Tri Delta in raising the funds necessary to support The Zeta Foundation," Cates said.

Prior to competing, Cates participated in other organizations, which have kept him active on Auburn's campus.

"I am a prior CWE counselor and am the Director of Auburn Family for Dance Marathon for this year," Cates said.

Cates said one of the greatest things he's had the opportunity to do is donate stem cells. He said the connection to Auburn occurred when he entered the registry on the concourse one day.

"I would have to say getting the opportunity to donate stem cells to a patient with Acute Myeloginis Leukemia, which was set up through Be The Match, a national bone marrow registry," Cates said."I was able to go to D.C. over Christmas break and donate these potentially life saving stem cells to a patient in France who was around my age. Really great experience."

View post:
Meet Curry Cates: 2017 Big Man on Campus - The Auburn Plainsman

Posted in Alabama Stem Cells | Comments Off on Meet Curry Cates: 2017 Big Man on Campus – The Auburn Plainsman

Bosan for establishing Islamic Biotechnology Centre – Pakistan Observer

Posted: April 28, 2017 at 1:51 am

Staff Reporter

Islamabad

Minister for National Food Security and Research Sikandar Hayat Khan Bosan called for establishing Islamic biotechnology center in order to develop the agriculture and related sectors for the socio-economic prosperity of Muslim countries. Addressing the 3rd International Conference on Agriculture, Food Security and Biotechnology on an other day, he said that government believes that practical collaboration among the Muslim countries in the cutting edge areas of modern biotechnology was the need of time. The event was organized by Pakistan Agricultural Research Council (PARC) in collaboration with COMSATS, Islamic Educational, Scientific and Cultural Organization (ISESCO) and CIMMYT. The aim of the conference was to share the international best practices of using the biotechnology for the development of agriculture sector and food security. The minister termed the exchange of eminent scientist for short term and graduating students among Islamic countries as another good form of cooperation. He called upon the scientists for encouraging and promoting smart agricultural practices to build the resilience in agri-sector. Pakistan was working on the development of infrastructure for using modern and innovative technologies including the biotechnology for uplift of agriculture, health and industrial sectors of the country, he added. Pakistan has improved its crop yield and productivity over the years and it was producing surplus of wheat, maize, potato and sugarcane, he added. He said that scientist and biotechnologist in Pakistan has achieved the diversification in seed development and moved to a higher value added seeds, particularly in the crops sector. The minister said that all the modern techniques should be replicated after tailor-made alterations keeping in view of local settings and environmental factors.

The rest is here:
Bosan for establishing Islamic Biotechnology Centre - Pakistan Observer

Posted in Biotechnology | Comments Off on Bosan for establishing Islamic Biotechnology Centre – Pakistan Observer

iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. – The Cerbat Gem

Posted: April 28, 2017 at 1:51 am

iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc.
The Cerbat Gem
iShares NASDAQ Biotechnology Index logo Vetr upgraded shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) from a hold rating to a buy rating in a research note issued to investors on Wednesday. They currently have $301.57 price target on ...
iShares NASDAQ Biotechnology Index (IBB) Stake Raised by Mycio Wealth Partners LLCSports Perspectives
iShares NASDAQ Biotechnology Index (IBB) Position Lowered by Bartlett & Co. LLCBBNS
The Crestwood Advisors Group LLC Acquires 5651 Shares of iShares NASDAQ Biotechnology Index (IBB)Petro Global News 24

all 6 news articles »

See the article here:
iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. - The Cerbat Gem

Posted in Biotechnology | Comments Off on iShares NASDAQ Biotechnology Index (IBB) Upgraded to Buy at Vetr Inc. – The Cerbat Gem

3SBio: Is this Chinese Biotechnology Stock a Buy? – Barron’s

Posted: April 28, 2017 at 1:51 am


Barron's
3SBio: Is this Chinese Biotechnology Stock a Buy?
Barron's
Shenyang-based 3SBio (1530.HK) is a biopharmaceutical pioneer that offers a unique play on China's rising demand for healthcare. The company is best known for its rheumatoid arthritis drug YSP, which accounts for 33% of revenues, and TPIAO, ...

Follow this link:
3SBio: Is this Chinese Biotechnology Stock a Buy? - Barron's

Posted in Biotechnology | Comments Off on 3SBio: Is this Chinese Biotechnology Stock a Buy? – Barron’s

Stem cells edited to fight arthritis – Washington University School of Medicine in St. Louis

Posted: April 28, 2017 at 1:51 am

Visit the News Hub

Goal is vaccine that targets inflammation in joints

Using CRISPR technology, a team of researchers led by Farshid Guilak, PhD, at Washington University School of Medicine in St. Louis, rewired stem cells' genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.

Using new gene-editing technology, researchers have rewired mouse stem cells to fight inflammation caused by arthritis and other chronic conditions. Such stem cells, known as SMART cells (Stem cells Modified for Autonomous Regenerative Therapy),develop into cartilage cells that produce a biologic anti-inflammatory drug that, ideally, will replace arthritic cartilage and simultaneously protect joints and other tissues from damage that occurs with chronic inflammation.

The cells were developed at Washington University School of Medicine in St. Louis and Shriners Hospitals for Children-St. Louis, in collaboration with investigators at Duke University and Cytex Therapeutics Inc., both in Durham, N.C. The researchers initially worked with skin cells taken from the tails of mice and converted those cells into stem cells. Then, using the gene-editing tool CRISPR in cells grown in culture, they removed a key gene in the inflammatory process and replaced it with a gene that releases a biologic drug that combats inflammation.

The research is availableonline April 27 in the journal Stem Cell Reports.

Our goal is to package the rewired stem cells as a vaccine for arthritis, which would deliver an anti-inflammatory drug to an arthritic joint but only when it is needed, said Farshid Guilak, PhD, the papers senior author and a professor of orthopedic surgery at Washington University School of Medicine. To do this, we needed to create a smart cell.

Many current drugs used to treat arthritis including Enbrel, Humira and Remicade attack an inflammation-promoting molecule called tumor necrosis factor-alpha (TNF-alpha). But the problem with these drugs is that they are given systemically rather than targeted to joints. As a result, they interfere with the immune system throughout the body and can make patients susceptible to side effects such as infections.

We want to use our gene-editing technology as a way to deliver targeted therapy in response to localized inflammation in a joint, as opposed to current drug therapies that can interfere with the inflammatory response through the entire body, said Guilak, also a professor of developmental biology and of biomedical engineering and co-director of Washington Universitys Center of Regenerative Medicine. If this strategy proves to be successful, the engineered cells only would block inflammation when inflammatory signals are released, such as during an arthritic flare in that joint.

As part of the study, Guilak and his colleagues grew mouse stem cells in a test tube and then used CRISPR technology to replace a critical mediator of inflammation with a TNF-alpha inhibitor.

Exploiting tools from synthetic biology, we found we could re-code the program that stem cells use to orchestrate their response to inflammation, said Jonathan Brunger, PhD, the papers first author and a postdoctoral fellow in cellular and molecular pharmacology at the University of California, San Francisco.

Over the course of a few days, the team directed the modified stem cells to grow into cartilage cells and produce cartilage tissue. Further experiments by the team showed that the engineered cartilage was protected from inflammation.

We hijacked an inflammatory pathway to create cells that produced a protective drug, Brunger said.

The researchers also encoded the stem/cartilage cells with genes that made the cells light up when responding to inflammation, so the scientists easily could determine when the cells were responding. Recently, Guilaks team has begun testing the engineered stem cells in mouse models of rheumatoid arthritis and other inflammatory diseases.

If the work can be replicated in animals and then developed into a clinical therapy, the engineered cells or cartilage grown from stem cells would respond to inflammation by releasing a biologic drug the TNF-alpha inhibitor that would protect the synthetic cartilage cells that Guilaks team created and the natural cartilage cells in specific joints.

When these cells see TNF-alpha, they rapidly activate a therapy that reduces inflammation, Guilak explained. We believe this strategy also may work for other systems that depend on a feedback loop. In diabetes, for example, its possible we could make stem cells that would sense glucose and turn on insulin in response. We are using pluripotent stem cells, so we can make them into any cell type, and with CRISPR, we can remove or insert genes that have the potential to treat many types of disorders.

With an eye toward further applications of this approach, Brunger added, The ability to build living tissues from smart stem cells that precisely respond to their environment opens up exciting possibilities for investigation in regenerative medicine.

Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs. Stem Cell Reports. April 27, 2017.

This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute on Aging of the National Institutes of Health (NIH), grant numbers AR061042, AR50245, AR46652, AR48182, AR067467, AR065956, AG15768, OD008586. Additional funding provided by the Nancy Taylor Foundation for Chronic Diseases; the Arthritis Foundation; the National Science Foundation (NSF), CAREER award number CBET-1151035; and the Collaborative Research Center of the AO Foundation, Davos, Switzerland.

Authors Farshid Guilak, and Vincent Willard have a financial interest in Cytex Therapeutics of Durham, N.C., which may choose to license this technology. Cytex is a startup founded by some of the investigators. They could realize financial gain if the technology eventually is approved for clinical use.

Washington University School of Medicines 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked seventh in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

See original here:
Stem cells edited to fight arthritis - Washington University School of Medicine in St. Louis

Posted in Cell Medicine | Comments Off on Stem cells edited to fight arthritis – Washington University School of Medicine in St. Louis

Capricor Therapeutics to Present at the Alliance for Regenerative Medicine’s Cell & Gene Therapy Investor Day – Yahoo Finance

Posted: April 28, 2017 at 1:51 am

LOS ANGELES, April 26, 2017 /PRNewswire/ --Capricor Therapeutics, Inc. (CAPR), a clinical-stage biotechnology company developing first-in-class biological therapies for cardiac and other medical conditions, today announced that Linda Marbn, Ph.D., president and chief executive officer, is scheduled to present at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 at The State Room in Boston, Massachusetts. The presentation will begin at approximately 9:40 a.m. eastern time and a live webcast of the event will be available at http://www.arminvestorday.com/webcast/.

About Capricor Therapeutics

Capricor Therapeutics, Inc. (CAPR) is a clinical-stage biotechnology company developing first-in-class biological therapies for cardiac and other medical conditions. Capricor's lead candidate, CAP-1002, is a cell-based candidate currently in clinical development for the treatment of Duchenne muscular dystrophy, myocardial infarction (heart attack), and heart failure. Capricor is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders. For more information, visit http://www.capricor.com.

Cautionary Note Regarding Forward-Looking Statements

Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor's product candidates; the initiation, conduct, size, timing and results of discovery efforts and clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; plans regarding current and future collaborative activities and the ownership of commercial rights; scope, duration, validity and enforceability of intellectual property rights; future royalty streams, expectations with respect to the expected use of proceeds from the recently completed offerings and the anticipated effects of the offerings, and any other statements about Capricor's management team's future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "believes," "plans," "could," "anticipates," "expects," "estimates," "should," "target," "will," "would" and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor's business is set forth in Capricor's Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on March 16, 2017, and in its Registration Statement on Form S-3, as filed with the Securities and Exchange Commission on September 28, 2015, together with prospectus supplements thereto. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements.

CAP-1002 is an Investigational New Drug and is not approved for any indications. Capricor's exosomes technology, including CAP-2003, has not yet been approved for clinical investigation.

For more information, please contact:

Corporate Capricor Therapeutics, Inc. AJ Bergmann, Vice President of Finance +1-310-358-3200 abergmann@capricor.com

Investor RelationsArgot Partners Kimberly Minarovich +1-212-600-1902 kimberly@argotpartners.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/capricor-therapeutics-to-present-at-the-alliance-for-regenerative-medicines-cell--gene-therapy-investor-day-300445808.html

Read this article:
Capricor Therapeutics to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day - Yahoo Finance

Posted in Cell Medicine | Comments Off on Capricor Therapeutics to Present at the Alliance for Regenerative Medicine’s Cell & Gene Therapy Investor Day – Yahoo Finance

Page 1,521«..1020..1,5201,5211,5221,523..1,5301,540..»